Price T Rowe Associates Inc Cytek Biosciences, Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 47,189 shares of CTKB stock, worth $241,607. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,189
Previous 39,503
19.46%
Holding current value
$241,607
Previous $219,000
40.18%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CTKB
# of Institutions
150Shares Held
74MCall Options Held
1KPut Options Held
0-
Black Rock Inc. New York, NY17.1MShares$87.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$60 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD8.25MShares$42.2 Million1.27% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$34.1 Million1.65% of portfolio
-
State Street Corp Boston, MA4.51MShares$23.1 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $689M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...